ArticleCancer immunology research2022

Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma.

Julia M DeRogatis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.